These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 19374970

  • 21. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
    Lufi D, Parish-Plass J, Gai E.
    Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
    [Abstract] [Full Text] [Related]

  • 22. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD.
    Kim Y, Shin MS, Kim JW, Yoo HJ, Cho SC, Kim BN.
    Hum Psychopharmacol; 2009 Mar; 24(2):95-102. PubMed ID: 19226534
    [Abstract] [Full Text] [Related]

  • 23. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC, Schoemaker MM.
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [Abstract] [Full Text] [Related]

  • 24. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
    Cho SC, Hwang JW, Kim BN, Lee HY, Kim HW, Lee JS, Shin MS, Lee DS.
    J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
    [Abstract] [Full Text] [Related]

  • 25. Anxiety, methylphenidate response, and working memory in children with ADHD.
    Bedard AC, Tannock R.
    J Atten Disord; 2008 Mar; 11(5):546-57. PubMed ID: 18094325
    [Abstract] [Full Text] [Related]

  • 26. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P, Panton R, Ironside S, Macpherson M, Williams T.
    J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
    [Abstract] [Full Text] [Related]

  • 27. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
    Langleben DD, Monterosso J, Elman I, Ash B, Krikorian G, Austin G.
    Psychiatry Res; 2006 Mar 30; 141(3):315-20. PubMed ID: 16516306
    [Abstract] [Full Text] [Related]

  • 28. [A pilot study of methylphenidate and parent training in the treatment of children with attention-deficit hiperactivity disorder].
    Montiel Nava C, Peña JA, Espina Mariñes G, Ferrer-Hernandez ME, López-Rubio A, Puertas-Sánchez S, Cardozo-Durán JJ.
    Rev Neurol; 2006 Mar 30; 35(3):201-5. PubMed ID: 12235578
    [Abstract] [Full Text] [Related]

  • 29. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
    Tomás Vila M, Aleu Pérez-Gramunt M, Beseler Soto B, Benac Prefasi M, Pantoja Martínez J, Pitarch Castellano I.
    An Pediatr (Barc); 2010 Aug 30; 73(2):78-83. PubMed ID: 20605120
    [Abstract] [Full Text] [Related]

  • 30. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX, Ma HW, Wan B, Dai XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug 30; 10(4):471-4. PubMed ID: 18706164
    [Abstract] [Full Text] [Related]

  • 31. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM, Coghill DR, Matthews K.
    J Child Psychol Psychiatry; 2006 Nov 30; 47(11):1184-94. PubMed ID: 17076758
    [Abstract] [Full Text] [Related]

  • 32. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.
    Keulers EH, Hendriksen JG, Feron FJ, Wassenberg R, Wuisman-Frerker MG, Jolles J, Vles JS.
    Eur J Paediatr Neurol; 2007 Jan 30; 11(1):21-8. PubMed ID: 17169593
    [Abstract] [Full Text] [Related]

  • 33. Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.
    Hwang JW, Kim B, Kim Y, Kim TH, Seo WS, Shin DW, Woo YJ, Yoo H, Lee JS, Lee JH, Lim MH, Chung YC, Jung CH, Yoo HK.
    Hum Psychopharmacol; 2013 Nov 30; 28(6):600-7. PubMed ID: 24519694
    [Abstract] [Full Text] [Related]

  • 34. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
    Işeri E, Kiliç BG, Senol S, Karabacak NI.
    Methods Find Exp Clin Pharmacol; 2007 Nov 30; 29(1):47-52. PubMed ID: 17344944
    [Abstract] [Full Text] [Related]

  • 35. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment.
    Gürkan K, Bilgiç A, Türkoglu S, Kiliç BG, Aysev A, Uslu R.
    J Psychopharmacol; 2010 Dec 30; 24(12):1810-8. PubMed ID: 19939861
    [Abstract] [Full Text] [Related]

  • 36. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P, Sever J, Zalsman G, Weizman A.
    Int Clin Psychopharmacol; 2008 Jul 30; 23(4):228-31. PubMed ID: 18446088
    [Abstract] [Full Text] [Related]

  • 37. [The utility of a continuous performance test embedded in virtual reality in measuring the effectiveness of MPH treatment in boys with ADHD].
    Shriki L, Weizer M, Pollak Y, Weiss PL, Rizzo AA, Gross-Tsur V.
    Harefuah; 2010 Jan 30; 149(1):18-23, 63. PubMed ID: 20422835
    [Abstract] [Full Text] [Related]

  • 38. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y, Doniger GM, Barak R, Simon ES, Hausdorff JM.
    J Child Neurol; 2007 Mar 30; 22(3):264-76. PubMed ID: 17621495
    [Abstract] [Full Text] [Related]

  • 39. Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder.
    Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC, Paule MG.
    Exp Clin Psychopharmacol; 2011 Apr 30; 19(2):145-53. PubMed ID: 21463072
    [Abstract] [Full Text] [Related]

  • 40. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.
    Expert Rev Neurother; 2009 Aug 30; 9(8):1121-31. PubMed ID: 19673602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.